NJ jury awards $25M to Ala. man in Accutane suitAssociated Press
Feb. 23, 2010
Swedish Journalist Who Worked To Demystify No-Go Zones Gets Shot In No-Go Zone
Canadian PM Justin Trudeau Says All Men Should Be Feminists, Calls For End to 'Bro Culture'
Disturbing Video Shows Brutal Assault On Elderly Teacher by Middle School Students
CNN Cuts Off Black Trump Supporter After He Rejects Concept Of 'White Guilt'
Here's The Source Of The 'End-of-World Prediction' That Interrupted TV Broadcasts in Orange County
ATLANTIC CITY, N.J. -- A New Jersey jury has hit the pharmaceutical company that makes Accutane with a $25.16 million judgment in a lawsuit filed by an Alabama man who blamed the drug for his inflammatory bowel disorder.
Thirty-eight-year-old Andrew McCarrell of Moody, Ala., took the acne drug in his 20s. He says Hoffmann-La Roche Inc. failed to adequately warn of its side effects. McCarrell eventually had his colon removed.
The compensatory damages award came Tuesday in a retrial. An appeals court overturned a $2.6 million judgment he won in May 2007.